MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of marketable
investment securities
$20,600,000
Net proceeds from
sale of common stock...
$2,869,552
Cash provided by
investing activities
$5,891,085
Cash provided by
financing activities
$2,869,552
Canceled cashflow
$14,708,915
Net increase
(decrease) in cash and cash...
-$1,000,084
Canceled cashflow
$8,760,637
Accounts payable
$700,126
Accrued expenses
$315,134
Stock-based compensation
expense
$242,497
Accrued interest income
-$106,258
Depreciation expense
$60,782
Purchases of marketable
investment securities
$14,708,915
Cash used in
operating activities
-$9,760,721
Canceled cashflow
$1,424,797
Net income (loss)
-$9,627,505
License and royalties
receivable
$1,053,985
Prepaid and other
current assets
$311,090
Amortization of discounts on
marketable investment...
$192,938
Back
Back
Cash Flow
source: myfinsight.com
Lipocine Inc. (LPCN)
Lipocine Inc. (LPCN)